Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir in Chronic Hepatitis E
NCT03282474Phase 2Completed
- Sponsor
- Hannover Medical School
- Start
- Dec 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sofosbuvir in chronic hepatitis E, sponsored by Hannover Medical School. Started Dec 2017; status: completed.
02
Drugs
sofosbuvir
03
Conditions
chronic hepatitis E
Beyond the preview
Go deeper on NCT03282474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282474.